查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827760

2025年全球微針藥物輸送系統市場報告

Microneedle Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，微針給藥系統的市場規模迅速擴張，從2024年的50.1億美元成長到2025年的58.6億美元，複合年成長率為17.1%。預測期內的成長可歸因於無痛給藥、增強患者依從性、慢性病管理、美容和美學應用以及疫苗接種。

預計未來幾年微針給藥系統市場將快速成長，到2029年將達到112.8億美元，複合年成長率為17.8%。預測期內的成長主要歸功於化妝品和美容應用、新興療法、兒科和老年醫學應用、全球健康計劃以及就地檢驗。預測期內的主要趨勢包括智慧微針、材料科學的進步、穿戴式技術的進步、可生物分解材料以及持續血糖監測。

微針藥物輸送系統是一種先進的醫療設備，它利用一系列微米大小的針頭，透過皮膚微創地輸送藥物、疫苗和其他治療，穿透角質層而不到達更深的神經末梢，最大限度地減少疼痛和不適。

微針藥物傳輸系統的主要技術包括固態微針技術、中空微針技術和可溶解微針技術。固體微針技術利用強化學塗層將乾燥的胜肽附著在微針陣列的尖端。這些固態微針通常微米為250至微米，呈貼片狀，可在室溫下保存。微針藥物輸送系統用於藥物輸送、疫苗接種和其他治療應用。它們廣泛應用於各種場合，包括診斷實驗室、生命科學實驗室、醫院、門診手術中心和其他醫療機構。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司最新報告系列的一部分，該系列提供微針給藥系統市場統計數據，例如全球市場規模、區域佔有率、微針給藥​​系統市場佔有率的競爭對手、微針給藥​​系統的詳細細分市場、市場趨勢和商機，以及在微針給藥系統行業取得成功所需的其他數據。本微針給藥系統市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為17.8%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。此影響將直接影響美國，包括對韓國生物相容性聚合物樹脂的關稅上調，以及無痛疫苗貼片和經皮給藥系統成本的上升，可能影響疫苗接種計畫。此外，由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，該影響也將更加廣泛。

預計不斷成長的研究工作和疫苗接種需求將推動微針給藥系統市場的成長。研究人員正在考慮將微針作為替代方案，以最大程度地減少收件人的疼痛。微針貼片最初是為流感和麻疹疫苗開發的，現在正用於接種 COVID-19 疫苗。例如，英國政府國家統計局在 2024 年 4 月預測，英國政府在研發 (R&D) 上的淨支出（不包括對歐盟研發預算的貢獻）將從 2021 年的 153.7 億美元（140 億英鎊）增加到 2022 年的 170.1 億美元（155 億英鎊），增幅為 10.5%。包括對歐盟研發預算和知識轉移活動的貢獻，預計 2022 年研發淨支出將達到 180.6 億美元（164.0 億英鎊），比 2021 年的 164.6 億美元（150.0 億英鎊）增加 8.9%。因此，有關疫苗接種過程的研究和需求不斷增加，正在推動微針給藥系統市場向前發展。

肥胖症盛行率的上升預計將推動未來微針給藥系統市場的成長。肥胖症是一種由體內脂肪過多引起的疾病，會對個人健康產生負面影響。微針給藥系統透過提供患者一種方便無痛的給藥方法，用於肥胖症管理。例如，英國政府機構健康改善和差異辦公室在 2024 年 5 月估計，到 2022-2023 年，64.0% 的 18 歲及以上英國成年人將超重或患有肥胖症。其中，26.2% 被歸類為肥胖。男性超重（包括肥胖）的盛行率（69.2%）高於女性（58.6%）。然而，成年人的肥胖率在性別之間相似，男性為 26.4%，女性為 26.2%。因此，肥胖症的日益普及正在推動微針藥物輸送系統市場的成長。

為了提供客戶可靠的服務，微針藥物輸送系統市場的主要企業正專注於射頻微針系統等產品創新。射頻微針系統是一種微創技術，它整合了微針和射頻能源，以改善藥物傳輸並刺激皮膚膠原蛋白的生成，用於治療和美容目的。例如，2023 年 2 月，美國醫療和美容設備製造商 Candela 推出了 Profound Matrix 系統。這個多應用系統包括 Sublime、Sublative RF 和尖端的 Matrix Pro施用器。 Sublime 和 Sublative RF 都利用雙極射頻 (RF) 技術來減少細紋和皺紋的出現，而 Matrix Pro 旨在刺激膠原蛋白的再生和生成。 Matrix Pro 是施用器旨在再生膠原蛋白和促進膠原蛋白生成的塗抹器。

微針給藥系統市場的主要企業正在建立夥伴關係以提高盈利。例如，2024 年 1 月，美國醫療和美容治療系統製造商 Cynosure 與美國美容皮膚科提供者 LaserAway 合作，將 Potenza RF 微針技術擴展到全國 LaserAway 商店。此次合作將使 LaserAway 能夠為美國更廣泛的患者群體提供射頻微針治療。提案強調，Potenza 是一款四模式射頻微針設備，將增強臨床醫生的客製化選項，並提升射頻微針技術的能力。

2022年11月，美國藥物輸送公司Kindeva Drug Delivery與Meridian Medical Technologies合併。 Kindeva Drug Delivery與Meridian Medical Technologies的合併將專注於多項關鍵技術，包括透過自動注射器進行的腸外給藥、吸入裝置、經皮給藥系統和皮內給藥技術。 Meridian Medical Technologies是一家專注於藥物傳輸系統的美國製造商。

微針藥物傳輸系統市場的主要企業包括 3M Company、Zosano Pharma Corporation、Becton-Dickinson Technologies、Nanopass Technologies、Corium Inc.、Valeritas Inc.、Microdermics、TheraJect Inc.、LTS Lohmann Therapie-Systeme AG、BioSerenTach (BT)、Sorran Therapntics Therapied、Rapha​​iatal、Tax​​ial. Co.Ltd.、NanoBiosciences LLC、AdminMed nanoBioSciences LLC、Nitto Denko Corporation、MyLife Technologies、Innoture Medical Technology Limited、Phillips-Medisize Corporation、Stemedica Cell Technologies Inc.、Candela Corporation、Dermaroller GmbH、Micropoint Technologies Technologies、Vaxess Technologies、Micron Biob​​ids、Micron Biob​​id、Krap​​yk、Badilla Point, Ticron​​id Inc.、Cutanos、Kimberly-Clark Corp. 與 Clearside BioMedical Inc.

2024年，微針藥物輸送系統市場最大的地區是北美。在微針藥物輸送系統市場分析中，歐洲是第二大地區。微針藥物輸送系統佔有率報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

微針藥物輸送系統市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

微針藥物傳輸系統市場包括水凝膠微針和可溶解微針的銷售。該市場的價值是「工廠門口」價值，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球微針藥物輸送系統：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球微針藥物輸送系統市場：成長率分析
  • 全球微針藥物輸送系統市場表現：規模與成長，2019-2024
  • 全球微針給藥系統市場預測：規模與成長，2024-2029年，2034年
  • 全球微針藥物輸送系統：總目標市場（TAM）

第6章 市場細分

  • 全球微針藥物輸送系統市場（技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 中空的
  • 多孔
  • 固體的
  • 其他
  • 全球微針藥物輸送系統市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 藥物輸送
  • 疫苗遞送
  • 其他
  • 全球微針藥物輸送系統市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 診斷實驗室
  • 生命科學
  • 實驗室
  • 醫院
  • 門診手術中心
  • 其他
  • 全球微針給藥系統市場：中空細分市場、類型、性能及預測（2019-2024、2024-2029、2034）
  • 實心中空微針
  • 塗層中空微針
  • 全球微針藥物輸送系統市場：多孔細分市場、類型、性能及預測（2019-2024、2024-2029、2034）
  • 多孔矽微針
  • 基於水凝膠的多孔微針
  • 全球微針給藥系統市場：固體細分、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 用於疫苗接種的固體微針
  • 用於藥物輸送的固體微針
  • 全球微針給藥系統市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 可溶解微針
  • 可生物分解的微針
  • 微量輸注系統

第7章 區域和國家分析

  • 全球微針藥物輸送系統市場：按地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球微針藥物輸送系統市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 微針藥物輸送系統市場：競爭格局
  • 微針藥物輸送系統市場：公司簡介
    • 3M Company
    • Zosano Pharma Corporation
    • Becton-Dickinson Technologies
    • Nanopass Technologies
    • Corium Inc.

第31章：其他領先和創新企業

  • Valeritas Inc.
  • Microdermics
  • TheraJect Inc.
  • LTS Lohmann Therapie-Systeme AG
  • BioSerenTach（BT）
  • Sorrento Therapeutics
  • DebIoTech
  • Raphas Co. Ltd.
  • QuadMedicine
  • Snvia Co. Ltd.
  • NanoBiosciences LLC
  • AdminMed nanoBioSciences LLC
  • Nitto Denko Corporation
  • MyLife Technologies
  • Innoture Medical Technology Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年微針藥物輸送系統市場：提供新機會的國家
  • 2029年微針藥物輸送系統市場：細分市場帶來新機會
  • 2029年微針藥物輸送系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21801u

Microneedle Drug Delivery Systems are sophisticated medical devices that utilize arrays of micron-sized needles to deliver drugs, vaccines, and other therapeutic agents through the skin with minimal invasiveness. They penetrate the stratum corneum without reaching deeper nerve endings, thereby minimizing pain and discomfort.

The main types of technologies used in microneedle drug delivery systems include solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, and others. In the solid microneedle method, peptides are dried onto the tips of a microneedle array, utilizing a coating of potent chemicals. These solid microneedles typically measure between 250 micrometers to 700 micrometers in length and are presented in patch form, allowing for storage at room temperature. Microneedle drug delivery systems find application in drug delivery, vaccine administration, and other therapeutic uses. They are employed in various settings such as diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgical centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The microneedles drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides microneedle drug delivery systems market statistics, including microneedle drug delivery systems industry global market size, regional shares, competitors with a microneedle drug delivery systems market share, detailed microneedles drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle drug delivery systems industry. This microneedle drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $5.01 billion in 2024 to $5.86 billion in 2025 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to pain-free drug delivery, enhanced patient compliance, chronic disease management, cosmetic and aesthetic applications, vaccine administration.

The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $11.28 billion in 2029 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to cosmetic and aesthetic applications, emergingTherapies, pediatric and geriatric use, global health initiatives, point-of-care testing. Major trends in the forecast period include smart microneedles, advancements in material science, advancements in wearable technology, biodegradable materials, continuous glucose monitoring.

The forecast of 17.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased duties on biocompatible polymer resins from South Korea, escalating costs for painless vaccine patches and transdermal drug delivery systems, potentially affecting immunization programs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing research efforts and demand for vaccination are anticipated to drive the growth of the microneedle drug delivery systems market. Researchers see microneedles as an alternative method for vaccine administration, allowing recipients to experience little to no pain. Initially developed for flu and measles vaccines, microneedle patches are now increasingly utilized for the delivery of COVID-19 vaccines as well. For example, in April 2024, the Office for National Statistics, a UK-based government agency, reported that the UK government's net expenditure on research and development (R&D), excluding contributions to the EU R&D budget, rose to $17.01 billion (£15.5 billion) in 2022, up from $15.37 billion (£14.0 billion) in 2021, reflecting a 10.5% increase. Including contributions to the EU R&D budget and knowledge transfer activities, total net expenditure on R&D reached $18.006 billion (£16.4 billion) in 2022, marking an 8.9% increase from $16.46 billion (£15.0 billion) in 2021. Thus, the rise in research and demand for the vaccination process is propelling the microneedle drug delivery systems market moving forward.

The rising prevalence of obesity is expected to drive the growth of the microneedle drug delivery systems market in the future. Obesity is a medical condition defined by an excess of body fat that can adversely affect an individual's health. Microneedle drug delivery systems are utilized for obesity management by providing a convenient and painless method for administering medications to patients. For example, in May 2024, the Office for Health Improvement and Disparities, a UK-based government agency, estimated that 64.0% of adults aged 18 and older in England were either overweight or living with obesity between 2022 and 2023. Of these individuals, 26.2% were classified as living with obesity. The prevalence of being overweight (including obesity) was higher in men (69.2%) than in women (58.6%). However, obesity rates among adults were comparable for both genders, with 26.4% of men and 26.2% of women living with obesity. Therefore, the increasing prevalence of obesity is driving the growth of the microneedle drug delivery systems market.

Major companies in the microneedle drug delivery systems market are concentrating on product innovation, such as radiofrequency microneedle systems, to deliver dependable services to their customers. A radiofrequency microneedle system is a minimally invasive technology that integrates microneedles with radiofrequency energy to improve drug delivery and stimulate collagen production in the skin for both therapeutic and cosmetic purposes. For example, in February 2023, Candela, a US-based medical aesthetic device manufacturer, introduced the Profound Matrix system. This multi-application system includes the Sublime, Sublative RF, and the cutting-edge Matrix Pro applicators. Both the Sublime and Sublative RF utilize bipolar radiofrequency (RF) technology to enhance the appearance of fine lines and wrinkles, while the Matrix Pro applicator is designed to regenerate and stimulate collagen production. It features a series of slender microneedles that deliver short-pulse RF energy to the skin, resulting in improved patient comfort, decreased downtime, and enhanced overall outcomes.

Major companies in the microneedle drug delivery systems market are forming partnerships to boost their profitability. For example, in January 2024, Cynosure, a US-based manufacturer of medical and aesthetic treatment systems, collaborated with LaserAway, a US-based provider of aesthetic dermatology, to expand the availability of the Potenza RF Microneedling technology to all LaserAway locations across the country. This partnership allows LaserAway to offer RF Microneedling to a wider patient demographic throughout the United States. Proponents emphasize that Potenza, a four-mode RF microneedling device, enhances customization options for clinicians and advances the capabilities of RF microneedling technology.

In November 2022, Kindeva Drug Delivery, a US-based drug delivery company, merged with Meridian Medical Technologies. The integration of Kindeva Drug Delivery and Meridian Medical Technologies will emphasize several key technologies, including parenteral drug delivery via autoinjectors, inhalation devices, transdermal delivery systems, and intradermal delivery techniques. Meridian Medical Technologies is a US-based manufacturer specializing in drug delivery systems.

Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.

North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The microneedle drug delivery systems market consists of sales of hydrogel microneedles and dissolvable microneedle. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microneedle drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microneedle drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Hollow; Porous; Solid; Other Technologies
  • 2) By Application: Drug Delivery; Vaccine Delivery; Other Applications
  • 3) By End-User: Diagnostics Laboratories; Life Sciences; Research Laboratories; Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Hollow: Solid Hollow Microneedles; Coated Hollow Microneedles
  • 2) By Porous: Porous Silicon Microneedles; Hydrogel-Based Porous Microneedles
  • 3) By Solid: Solid Microneedles For Vaccination; Solid Microneedles For Drug Delivery
  • 4) By Other Technologies: Dissolving Microneedles; Biodegradable Microneedles; Micro-Infusion Systems
  • Companies Mentioned: 3M Company; Zosano Pharma Corporation; Becton-Dickinson Technologies; Nanopass Technologies; Corium Inc.; Valeritas Inc.; Microdermics; TheraJect Inc.; LTS Lohmann Therapie-Systeme AG; BioSerenTach (BT); Sorrento Therapeutics; Debiotech; Raphas Co. Ltd.; QuadMedicine; Snvia Co. Ltd.; NanoBiosciences LLC; AdminMed nanoBioSciences LLC; Nitto Denko Corporation; MyLife Technologies; Innoture Medical Technology Limited; Phillips-Medisize Corporation; Stemedica Cell Technologies Inc.; Candela Corporation; Dermaroller GmbH; Micropoint Technologies; Vaxess Technologies; Micron Biomedical Inc.; Kindeva Drug Delivery; Gurnet Point Capital; Moonlight Therapeutics Inc.; Cutanos; Kimberly-Clark Corp.; Clearside BioMedical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microneedle Drug Delivery Systems Market Characteristics

3. Microneedle Drug Delivery Systems Market Trends And Strategies

4. Microneedle Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Microneedle Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Microneedle Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Microneedle Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Microneedle Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Microneedle Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Microneedle Drug Delivery Systems Total Addressable Market (TAM)

6. Microneedle Drug Delivery Systems Market Segmentation

  • 6.1. Global Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hollow
  • Porous
  • Solid
  • Other Technologies
  • 6.2. Global Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery
  • Vaccine Delivery
  • Other Applications
  • 6.3. Global Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics Laboratories
  • Life Sciences
  • Research Laboratories
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.4. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Hollow, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Hollow Microneedles
  • Coated Hollow Microneedles
  • 6.5. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Porous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Porous Silicon Microneedles
  • Hydrogel-Based Porous Microneedles
  • 6.6. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Solid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Microneedles For Vaccination
  • Solid Microneedles For Drug Delivery
  • 6.7. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dissolving Microneedles
  • Biodegradable Microneedles
  • Micro-Infusion Systems

7. Microneedle Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Microneedle Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Microneedle Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microneedle Drug Delivery Systems Market

  • 8.1. Asia-Pacific Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microneedle Drug Delivery Systems Market

  • 9.1. China Microneedle Drug Delivery Systems Market Overview
  • 9.2. China Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microneedle Drug Delivery Systems Market

  • 10.1. India Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microneedle Drug Delivery Systems Market

  • 11.1. Japan Microneedle Drug Delivery Systems Market Overview
  • 11.2. Japan Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microneedle Drug Delivery Systems Market

  • 12.1. Australia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microneedle Drug Delivery Systems Market

  • 13.1. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microneedle Drug Delivery Systems Market

  • 14.1. South Korea Microneedle Drug Delivery Systems Market Overview
  • 14.2. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microneedle Drug Delivery Systems Market

  • 15.1. Western Europe Microneedle Drug Delivery Systems Market Overview
  • 15.2. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microneedle Drug Delivery Systems Market

  • 16.1. UK Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microneedle Drug Delivery Systems Market

  • 17.1. Germany Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microneedle Drug Delivery Systems Market

  • 18.1. France Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microneedle Drug Delivery Systems Market

  • 19.1. Italy Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microneedle Drug Delivery Systems Market

  • 20.1. Spain Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microneedle Drug Delivery Systems Market

  • 21.1. Eastern Europe Microneedle Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microneedle Drug Delivery Systems Market

  • 22.1. Russia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microneedle Drug Delivery Systems Market

  • 23.1. North America Microneedle Drug Delivery Systems Market Overview
  • 23.2. North America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microneedle Drug Delivery Systems Market

  • 24.1. USA Microneedle Drug Delivery Systems Market Overview
  • 24.2. USA Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microneedle Drug Delivery Systems Market

  • 25.1. Canada Microneedle Drug Delivery Systems Market Overview
  • 25.2. Canada Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microneedle Drug Delivery Systems Market

  • 26.1. South America Microneedle Drug Delivery Systems Market Overview
  • 26.2. South America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microneedle Drug Delivery Systems Market

  • 27.1. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microneedle Drug Delivery Systems Market

  • 28.1. Middle East Microneedle Drug Delivery Systems Market Overview
  • 28.2. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microneedle Drug Delivery Systems Market

  • 29.1. Africa Microneedle Drug Delivery Systems Market Overview
  • 29.2. Africa Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microneedle Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Microneedle Drug Delivery Systems Market Competitive Landscape
  • 30.2. Microneedle Drug Delivery Systems Market Company Profiles
    • 30.2.1. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Zosano Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton-Dickinson Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Nanopass Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Corium Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Microneedle Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Valeritas Inc.
  • 31.2. Microdermics
  • 31.3. TheraJect Inc.
  • 31.4. LTS Lohmann Therapie-Systeme AG
  • 31.5. BioSerenTach (BT)
  • 31.6. Sorrento Therapeutics
  • 31.7. Debiotech
  • 31.8. Raphas Co. Ltd.
  • 31.9. QuadMedicine
  • 31.10. Snvia Co. Ltd.
  • 31.11. NanoBiosciences LLC
  • 31.12. AdminMed nanoBioSciences LLC
  • 31.13. Nitto Denko Corporation
  • 31.14. MyLife Technologies
  • 31.15. Innoture Medical Technology Limited

32. Global Microneedle Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microneedle Drug Delivery Systems Market

34. Recent Developments In The Microneedle Drug Delivery Systems Market

35. Microneedle Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Microneedle Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Microneedle Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Microneedle Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer